Texas Capital Bancshares’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$63.6K Buy
+2,495
New +$61.6K 0.03% 105
2023
Q1
Sell
-4,303
Closed -$220K 86
2022
Q4
$220K Buy
+4,303
New +$206K 0.15% 80
2022
Q3
Sell
-4,220
Closed -$221K 77
2022
Q2
$221K Buy
+4,220
New +$215K 0.17% 75
2019
Q3
Sell
-8,044
Closed -$331K 54
2019
Q2
$331K Buy
8,044
+2,699
+50% +$107K 0.55% 38
2019
Q1
$215K Hold
5,345
0.39% 53
2018
Q4
$221K Hold
5,345
0.5% 50
2018
Q3
$223K Buy
+5,345
New +$206K 0.47% 45
2015
Q4
Sell
-7,740
Closed -$231K 84
2015
Q3
$231K Buy
7,740
+139
+2% +$4.46K 0.19% 83
2015
Q2
$242K Sell
7,601
-447
-6% -$14.6K 0.16% 101
2015
Q1
$266K Sell
8,048
-778
-9% -$24.7K 0.15% 119
2014
Q4
$261K Sell
8,826
-2,838
-24% -$81.4K 0.14% 123
2014
Q3
$327K Buy
11,664
+307
+3% +$8.62K 0.19% 82
2014
Q2
$320K Hold
11,357
0.2% 85
2014
Q1
$346K Buy
+11,357
New +$339K 0.22% 80

Other funds holding PFE

Texas Capital Bancshares's PFE Position: Q3 2025 in Review

Texas Capital Bancshares opened a new position in Pfizer (PFE) in Q3 2025: 2,495 shares worth $63.6K. The stake represents 0.03% of the portfolio and ranks #105 among its holdings. This is a return to the name: Texas Capital Bancshares previously reported a position in PFE as recently as Q4 2022.

Texas Capital Bancshares first reported a position in PFE in Q1 2014 and has held it in 14 quarters since. The position peaked at $346K in Q1 2014. 2,812 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Texas Capital Bancshares held 2,495 shares of Pfizer worth $63.6K as of Q3 2025.
  • Pfizer was a new Texas Capital Bancshares position in Q3 2025.
  • Pfizer made up 0.03% of Texas Capital Bancshares's portfolio in Q3 2025, its #105 holding.
  • Texas Capital Bancshares first reported a position in Pfizer in Q1 2014 and has held it in 14 quarters since.
  • Texas Capital Bancshares's Pfizer position peaked at $346K in Q1 2014.
  • 2,812 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Texas Capital Bancshares's 13F filing for Q3 2025, filed 13 Nov 2025.